Dr. Ellis Discusses the Future of the PI3-Kinase Pathway

PI3K-AKT Pathway ExplainedПодробнее

Dr. Ellis Discusses Genome Forward Breast Cancer TreatmentПодробнее

The PI3K Signaling PathwayПодробнее

Dr. Matthew Ellis on the Future of TCGAПодробнее

The PI3K/AKT signalling pathwayПодробнее

PI3 KINASE SIGNALING PATHWAYПодробнее

PI3K AKT mTOR Pathway (and the effects)Подробнее

AKT/PKB Signaling Pathway | PI3k SignalingПодробнее

PI3k/AKT/mTOR PathwayПодробнее

Dr. Ellis Discusses the FALCON TrialПодробнее

Targeting the PI3K Pathway in the Therapy of Breast Cancer - by Jose Baselga, MD, PhDПодробнее

PI3K signalling: from basic biology to new cancer therapiesПодробнее

IMPAKT 2013: The future of PI3K/AKT/mTOR inhibitors in breast cancerПодробнее

Progress Report: SU2C-PI3K Dream TeamПодробнее

Where Your Money Goes: SU2C-PI3K Pathway Dream TeamПодробнее

Dr. Baselga Discusses Targeting PI3K in Breast CancerПодробнее

Dr. Ellis on Measuring Endocrine Therapy Efficacy With Ki67Подробнее

Role of the MAP Kinase Pathway in NSCLCПодробнее

Dr. Ellis Considers the Use of Biosimilars in OncologyПодробнее